
2.64MUSD
-0.04
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US66988N2053
CUSIP
66988N106
Sector
Healthcare
Industry
Pharmaceuticals
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.10
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-0.84
Wall Street Target Price
15.50
EPS Estimate Current Year
-0.35
EPS Estimate Next Year
0.16
EPS Estimate Current Quarter
-0.32
EPS Estimate Next Quarter
-0.23
Most Recent Quarter
-
Revenue TTM
24,920,000
Gross Profit TTM
313,000
EBITDA
-36,206,000
Profit Margin
-128.61%
Return On Assets TTM
-25.84%
Return On Equity TTM
-2098.89%
Revenue Per Share TTM
1.045
Qtly Revenue Growth YOY
64.20%
Diluted Eps TTM
-0.84
Qtly Earnings Growth YOY
-61.50%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
2.2951
Price Book MRQ
5.1023
Enterprise Value Revenue
1
Enterprise Value EBITDA
0
16.85
0.00%